The relaunched site will cover longevity research, therapeutics, biomarkers, clinics, regulation, capital and data ...
Camp4 Therapeutics FY25 GAAP EPS missed expectations, but ended the year with a robust cash position. Check out why CAMP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results